Mondesir JM - Search Results

1

Phase II study of elliptinium in advanced breast cancer.

Rouësse JG, Le Chevalier T, Caille P, Mondesir JM, Sancho-Garnier H, May-Levin F, Spielmann M, De Jager R, Amiel JL. Rouësse JG, et al. Among authors: mondesir jm. Cancer Treat Rep. 1985 Jun;69(6):707-8. Cancer Treat Rep. 1985. PMID: 4016774

2

Phase II trial of elliptinium in advanced renal cell carcinoma.

Caillé P, Mondesir JM, Droz JP, Kerbrat P, Goodman A, Ducret JP, Theodore C, Spielman M, Rouëssé J, Amiel JL. Caillé P, et al. Among authors: mondesir jm. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):901-2. Cancer Treat Rep. 1985. PMID: 4016798

3

Phase II study of elliptinium acetate salvage treatment of advanced breast cancer.

Rouëssé J, Spielmann M, Turpin F, Le Chevalier T, Azab M, Mondésir JM. Rouëssé J, et al. Among authors: mondesir jm. Eur J Cancer. 1993;29A(6):856-9. doi: 10.1016/s0959-8049(05)80424-1. Eur J Cancer. 1993. PMID: 8484977 Clinical Trial.

4

[2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)].

Rouëssé J, Huertas D, Sancho-Garnier H, Le Chevalier T, Amiel JL, Brulé G, Tursz T, Mondésir JM. Rouëssé J, et al. Among authors: mondesir jm. Bull Cancer. 1981;68(5):437-41. Bull Cancer. 1981. PMID: 7037078 Clinical Trial. French.

5

Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis.

Mondesir JM, Bidart JM, Goodman A, Alberici GF, Caille P, Troalen F, Rouesse J, Bohuon C, Gralla RJ, Einzig AI, et al. Mondesir JM, et al. J Clin Oncol. 1985 May;3(5):735-40. doi: 10.1200/JCO.1985.3.5.735. J Clin Oncol. 1985. PMID: 3998787

6

[Manifestations of cerebral metastases: diagnostic and therapeutic importance of research on their primary sites in 120 cases].

Rouëssé J, Le Chevalier T, Constans JP, Caille P, Mondésir JM, Boddaert A. Rouëssé J, et al. Among authors: mondesir jm. Bull Cancer. 1982;69(2):159-63. Bull Cancer. 1982. PMID: 7126887 French.

7

[Mesenchymal breast sarcomas. Apropos of 25 cases].

Spielmann M, Toussaint C, Malcoste G, Le Chevalier T, Mondésir JM, Contesso G, Sarrazin D, Genin J, Rouesse J. Spielmann M, et al. Among authors: mondesir jm. Bull Cancer. 1985;72(3):202-9. Bull Cancer. 1985. PMID: 3000484 French.

8

Inhibition of acetylcholinesterase and cholinesterase by ellipticine derivatives.

Alberici GF, Bidart JM, Moingeon P, Mondesir JM, Bohuon C, De Jager R. Alberici GF, et al. Among authors: mondesir jm. Biochem Pharmacol. 1983 Sep 15;32(18):2837-9. doi: 10.1016/0006-2952(83)90105-3. Biochem Pharmacol. 1983. PMID: 6626256 No abstract available.

9

Conjugates of elliptinium acetate with mouse monoclonal anti-alpha-fetoprotein antibodies or Fab fragments: in vitro cytotoxic effects upon human hepatoma cell lines.

Alberici GF, Pallardy M, Manil L, Dessaux JJ, Fournier J, Mondesir JM, Bohuon C, Gros P. Alberici GF, et al. Among authors: mondesir jm. Int J Cancer. 1988 Feb 15;41(2):309-14. doi: 10.1002/ijc.2910410224. Int J Cancer. 1988. PMID: 2448254

10

Human antibodies to the antineoplastic drug elliptinium: characterization and structure-activity relationships.

Alberici GF, Fellous R, Bidart JM, Troalen F, Mondesir JM, Goodman A, Ho DH, Bohuon C. Alberici GF, et al. Among authors: mondesir jm. J Allergy Clin Immunol. 1986 Apr;77(4):624-30. doi: 10.1016/0091-6749(86)90356-8. J Allergy Clin Immunol. 1986. PMID: 2420854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters